Literature DB >> 27647395

[Current status and perspectives of radiotherapy for esophageal cancer].

S X Wu1, L H Wang2.   

Abstract

Esophageal cancer is one of the most common cancers in China. More than 80% of esophageal cancer patients are diagnosed at a late stage and are not eligible for surgery. Radiotherapy is one of the most important modalities in esophageal cancer treatment. Here we reviewed the advances in esophageal cancer radiotherapy and radiotherapy-based combined-modality therapy, such as optimization of radiation dose and target volume, application of precise radiotherapy technique and the integration of radiotherapy with chemotherapy and targeted therapy.

Entities:  

Mesh:

Year:  2016        PMID: 27647395     DOI: 10.3760/cma.j.issn.0253-3766.2016.09.003

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  4 in total

1.  Application Value of Gastroenterography Combined With CT in the Evaluation of Short-Term Efficacy and Prognosis in Patients With Esophageal Cancer Radiotherapy.

Authors:  Liangliang Xue; Linning E; Zhifeng Wu; Dongqiang Guo
Journal:  Front Surg       Date:  2022-06-09

2.  Clinical diagnostic value of digestive endoscopic narrow-band imaging in early esophageal cancer.

Authors:  Zhenhua Su; Liang Wang; Sichen Wei; Xinliang Wei; Yu Kong; Weiwei Wang; Ruixue Guo; Xiaomeng Shi
Journal:  Oncol Lett       Date:  2019-04-19       Impact factor: 2.967

3.  microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.

Authors:  Kexin Jiang; Huawei Zou
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

4.  Treatment of esophageal cancer with radiation therapy -a pan-Chinese survey of radiation oncologists.

Authors:  Yun Zhang; Jing Liu; Wencheng Zhang; Weiye Deng; Jinbo Yue
Journal:  Oncotarget       Date:  2017-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.